Power of Attorney Filing by Veet Misra for Ascentage Pharma Group International

This filing details a Power of Attorney granted by Veet Misra, Chief Financial Officer of Ascentage Pharma Group International, to Thomas J. Knapp and Leslie Brault. The attorneys-in-fact are authorized to act on behalf of Ms. Misra in all necessary capacities for filing documents with the U.S. Securities and Exchange Commission (SEC) related to the company's securities. This includes preparing, executing, and submitting various forms such as Forms 3, 4, and 5, Schedules 13D and 13G, and Forms 144, utilizing the SEC's EDGAR system. The power of attorney also covers managing Ms. Misra's EDGAR account, obtaining information on company equity securities from third parties, and generally performing all acts necessary for compliance with Section 13 and Section 16 of the Securities Exchange Act of 1934 and Rule 144 of the Securities Act of 1933. The power of attorney remains in effect until Ms. Misra is no longer required to file these documents, unless earlier revoked. This document revokes all previous powers of attorney regarding the same subject matter.